XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Expense
Expense
Three Months Ended
September 30,		Nine Months Ended
September 30,
(in thousands)2024202320242023
Cost of revenue
$6,894 $6,410 $20,558 $22,497 
Selling and marketing
14,169 10,401 41,621 43,410 
Research and development
7,308 7,375 22,779 24,286 
General and administrative
8,842 7,113 23,260 19,890 
$37,213 $31,299 $108,218 $110,083 
Income tax benefit
$(512)$(316)$(1,377)$(1,569)
Schedule of Stock Based Compensation Award Granted
Grants
Nine Months Ended
September 30, 2024
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
1,306 $80,642 
Non-qualified stock options
1,789 $46,365 
Performance stock options (2)
566 $13,921 
Common stock
11 $750 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of common stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. For the performance stock options granted in the nine months ended September 30, 2024, 25% can vest on the first anniversary of the grant date, and 75% can vest on the second anniversary of the grant date, based on the achievement of specific performance conditions. The options expire ten years from the grant date.